These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16921445)

  • 21. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
    Disertori M; Zeni P; Quintarelli S; Bonmassari R
    G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the risk of recurrences after pulmonary vein isolation: what is the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers?
    Steinberg JS; Garikipati NV
    Cardiology; 2010; 117(1):11-3. PubMed ID: 20881388
    [No Abstract]   [Full Text] [Related]  

  • 23. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
    Casaclang-Verzosa G; Gersh BJ; Tsang TS
    J Am Coll Cardiol; 2008 Jan; 51(1):1-11. PubMed ID: 18174029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular basis of remodelling in atrial fibrillation].
    Dobrev D
    Dtsch Med Wochenschr; 2004 Apr; 129(15):827-30. PubMed ID: 15054689
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
    Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
    Levine MJ; Schweitzer P
    Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation.
    Wachtell K; Devereux RB; Lyle PA
    Curr Cardiol Rep; 2006 Sep; 8(5):356-64. PubMed ID: 16956451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renin-angiotensin-aldosterone system in atrial fibrillation: a new therapeutic target?
    Freestone B; Beevers DG; Lip GY
    J Hum Hypertens; 2004 Jul; 18(7):461-5. PubMed ID: 14973520
    [No Abstract]   [Full Text] [Related]  

  • 32. [Renin-angiotensin system modulation: instructions for use].
    Bellis A; Rozza F; Crispo S; Trimarco B
    G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual renin-angiotensin system blockade in heart failure.
    McMurray JJ; Granger CB; Ostergren J; Yusuf S; Pfeffer MA; Swedberg K
    J Am Coll Cardiol; 2009 Jul; 54(3):278; author reply 279-80. PubMed ID: 19589444
    [No Abstract]   [Full Text] [Related]  

  • 34. Atrial fibrillation and atrial fibrosis.
    Tan AY; Zimetbaum P
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):625-9. PubMed ID: 21633248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.
    Kuzniatsova N; Shantsila E; Lip GY
    Nat Rev Cardiol; 2010 Aug; 7(8):428-30. PubMed ID: 20657612
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis.
    Jibrini MB; Molnar J; Arora RR
    Am J Ther; 2008; 15(1):36-43. PubMed ID: 18223352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of renin-angiotensin system: a supplementary treatment for circumferential pulmonary vein isolation in treating persistent atrial fibrillation.
    Dai SM; Zhang S; Chu JM; Guo YH; Chen KP; Yao Sy
    Med Hypotheses; 2007; 69(4):767-72. PubMed ID: 17475415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: need for a definitive trial.
    Celik T; Iyisoy A
    Int J Cardiol; 2008 Jul; 127(2):276-7; author reply 278-9. PubMed ID: 17692408
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin converting-enzyme inhibitors and candesartan have no effects on atrial fibrillation after cardiac surgery: comment on: Mehmet Ozaydin et al. "Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation".
    Mariscalco G; Dominici C; Banach M; Sala A
    Int J Cardiol; 2010 Jul; 142(2):209-10. PubMed ID: 19101048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhythm control for atrial fibrillation: non-channel antiarrhythmic drugs are en vogue.
    Van Gelder IC
    Cardiovasc Res; 2007 Apr; 74(1):8-10. PubMed ID: 17336952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.